Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• FFRCT: A new paradigm for predicting ischemia
• Friedewald equation may underestimate LDL levels
• Newborn congenital heart defect screening burden low, requires consistency
• Online medical professionalism statement targets social media use
• Slight decreases in BP seen with alternative therapies
• Uncertainty in the era of health care reform L. Samuel Wann, MD, MACC, FESC
• FDA approved Kcentra for urgent reversal of anticoagulation
• FDA approves Liptruzet for LDL cholesterol
• Cost of HF care projected to double by 2030
• Patients benefited from follow-up care after evaluation for chest pain
• Publication bias found in emerging CVD biomarker research
• Societies update clinical competencies needed for performing PCI
• BRUISE CONTROL: Surgery with continued warfarin reduced adverse outcomes
• Borderline lesions may pose higher risk than previously thought
• CREST substudy: Angioplasty after carotid stent deployment lowers restenosis risk
• Hypothermic treatment improved survival for young cardiac arrest patients
• Lung transplants donated after cardiac death yielded favorable outcomes
• Post-approval study confirms improved survival with HeartMate II LVAD
• Prediction models may overestimate survival for PAH patients awaiting lung transplant
• PROTECT AF: Long-term data confirm safety, sustained efficacy of Watchman device
• Societies release consensus on diagnosis, management of inherited arrhythmias
• Survey: HRS members support reuse of cardiac implantable devices
• Waitlist mortality unchanged for sickest pediatric heart transplant patients
• Available drug information on the Internet: A focus on vetted sites Sally A. Arif, PharmD, BCPS
• A Trial of Vitamin D Therapy in Patients with Heart Failure
• ADVANCE III
• BLOCK HF
• BRUISE CONTROL
• C-CURE
• CREST
• PROTECT AF
• VIRGO